Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumors

Por Ghadimi, Markus P, Lopez, Gonzalo, Torres, Keila E., Belousov, Roman, Young, Eric D., Liu, Jeffery, Brewer, Kari J., Hoffman, Aviad, Lusby, Kristelle, Lazar, Alexander J, Pollock, Raphael E., Lev, Dina
Publicado em 2012

Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors

Por Ghadimi, Markus P., Young, Eric D., Belousov, Roman, Zhang, Yiqun, Lopez, Gonzalo, Lusby, Kristelle, Kivlin, Christine, Demicco, Elizabeth G., Creighton, Chad J., Lazar, Alexander J., Pollock, Raphael E., Lev, Dina
Publicado em 2012

Pleomorphic liposarcoma: clinical observations and molecular variables

Por Ghadimi, Markus P., Liu, Ping, Peng, Tingsheng, Bolshakov, Svetlana, Young, Eric D., Torres, Keila E., Colombo, Chiara, Hoffman, Aviad, Broccoli, Dominique, Hornick, Jason L., Lazar, Alexander J., Pisters, Peter, Pollock, Raphael E., Lev, Dina
Publicado em 2011

Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors

Por Torres, Keila E., Zhu, Quan-Sheng, Bill, Katelynn, Lopez, Gonzalo, Ghadimi, Markus P., Xie, Xianbiao, Young, Eric D., Liu, Juehui, Nguyen, Theresa, Bolshakov, Svetlana, Belousov, Roman, Wang, Suizhau, Lahat, Guy, Liu, Jun, Hernandez, Belinda, Lazar, Alexander J., Lev, Dina
Publicado em 2011